These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29800647)

  • 1. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
    Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
    J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING-associated lung disease in mice relies on T cells but not type I interferon.
    Luksch H; Stinson WA; Platt DJ; Qian W; Kalugotla G; Miner CA; Bennion BG; Gerbaulet A; Rösen-Wolff A; Miner JJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):254-266.e8. PubMed ID: 30772497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.
    Motwani M; Pawaria S; Bernier J; Moses S; Henry K; Fang T; Burkly L; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7941-7950. PubMed ID: 30944222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
    Siedel H; Roers A; Rösen-Wolff A; Luksch H
    Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
    Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a constitutively active human
    Martin GR; Henare K; Salazar C; Scheidl-Yee T; Eggen LJ; Tailor PP; Kim JH; Podstawka J; Fritzler MJ; Kelly MM; Yipp BG; Jirik FR
    Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31221625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet B Irradiation Causes Stimulator of Interferon Genes-Dependent Production of Protective Type I Interferon in Mouse Skin by Recruited Inflammatory Monocytes.
    Sontheimer C; Liggitt D; Elkon KB
    Arthritis Rheumatol; 2017 Apr; 69(4):826-836. PubMed ID: 27863141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
    Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
    J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
    Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production.
    Rodriguez-Garcia E; Zabaleta N; Gil-Farina I; Gonzalez-Aparicio M; Echeverz M; Bähre H; Solano C; Lasa I; Gonzalez-Aseguinolaza G; Hommel M
    J Immunol; 2021 Jan; 206(2):376-385. PubMed ID: 33298616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
    Roifman CM; Zhang J; Chitayat D; Sharfe N
    Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STING-associated vasculopathy develops independently of IRF3 in mice.
    Warner JD; Irizarry-Caro RA; Bennion BG; Ai TL; Smith AM; Miner CA; Sakai T; Gonugunta VK; Wu J; Platt DJ; Yan N; Miner JJ
    J Exp Med; 2017 Nov; 214(11):3279-3292. PubMed ID: 28951494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
    Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
    J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression.
    Nazmi A; Field RH; Griffin EW; Haugh O; Hennessy E; Cox D; Reis R; Tortorelli L; Murray CL; Lopez-Rodriguez AB; Jin L; Lavelle EC; Dunne A; Cunningham C
    Glia; 2019 Jul; 67(7):1254-1276. PubMed ID: 30680794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
    Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
    EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
    David C; Frémond ML
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
    Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
    Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING regulates BCR signaling in normal and malignant B cells.
    Tang CA; Lee AC; Chang S; Xu Q; Shao A; Lo Y; Spalek WT; Pinilla-Ibarz JA; Del Valle JR; Hu CA
    Cell Mol Immunol; 2021 Apr; 18(4):1016-1031. PubMed ID: 32999453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
    Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
    J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell expression of a STING gain-of-function mutation initiates pulmonary lymphocytic infiltration.
    Gao KM; Chiang K; Jiang Z; Korkmaz FT; Janardhan HP; Trivedi CM; Quinton LJ; Gingras S; Fitzgerald KA; Marshak-Rothstein A
    Cell Rep; 2024 Apr; 43(4):114114. PubMed ID: 38625791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.